← Back to Search
Radiomics: Images Are More Than Pictures, They Are Data
R. Gillies, P. Kinahan, H. Hricak
Published 2016 · Medicine
Download PDFAnalyze on Scholarcy
This report describes the process of radiomics, its challenges, and its potential power to facilitate better clinical decision making, particularly in the care of patients with cancer.
This paper references
Automatic classification of prostate cancer Gleason scores from multi - parametric magnetic resonance images . Proc Natl Acad Sci USA ( in press ) . Historical Perspective and Planned Goals
D Fehr (2014)
Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials.
L. Shankar (2006)
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach
H. Aerts (2014)
The Concordance Correlation Coefficient for Repeated Measures Estimated by Variance Components
J. Carrasco (2009)
Results of the Lynn Sage Second‐Opinion Program for local therapy in patients with breast carcinoma
J. Clauson (2002)
It's All About the Test: The Complexity of Companion Diagnostic Co-development in Personalized Medicine
S. Bates (2014)
RECIST revised: implications for the radiologist. A review article on the modified RECIST guideline
E. L. van Persijn van Meerten (2009)
Texture features on T2-weighted magnetic resonance imaging: new potential biomarkers for prostate cancer aggressiveness.
A. Vignati (2015)
Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers.
D. Hayes (1996)
Radiogenomic analysis to identify imaging phenotypes associated with drug response gene expression programs in hepatocellular carcinoma.
M. Kuo (2007)
First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations.
L. Sequist (2008)
CT-based radiomic signature predicts distant metastasis in lung adenocarcinoma.
T. Coroller (2015)
The impact of pathology review on treatment recommendations for patients with adenocarcinoma of the prostate.
P. Nguyen (2004)
J Clin Oncol
Egfr Matic (2008)
Standardization of Multiparametric Prostate MR Imaging Using PI-RADS
J. Bomers (2014)
Imaging in - tratumor heterogeneity : role in therapy response , resistance , and clinical outcome
JP O’Connor (2015)
Behavior of incidence lung cancers in the CT arm of the National Lung Screening Trial
Drug development: Raise standards for preclinical cancer research
C. G. Begley (2012)
Computer-aided diagnosis in medical imaging: Historical review, current status and future potential
K. Doi (2007)
Fact sheet: President Obama's precision medicine initiative. The White House Web site
ACR CT Accreditation Program and the Lung Cancer Screening Program Designation.
E. Kazerooni (2016)
Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.
M. Gerlinger (2012)
CT-guided biopsies of metabolically active bone lesions: applications and clinical impact
B Klaeser (2010)
TU-CD-BRB-02: BEST IN PHYSICS (JOINT IMAGING-THERAPY): Identification of Molecular Phenotypes by Integrating Radiomics and Genomics
P. Grossmann (2015)
The ACR BI-RADS experience: learning from history.
E. Burnside (2009)
Mapping Institution-Specific Study Descriptions to RadLex Playbook Entries
T. Mabotuwana (2013)
Decoding global gene expression programs in liver cancer by noninvasive imaging
E. Segal (2007)
Data sharing: Empty archives
B. Nelson (2009)
Journals unite for reproducibil
FDG-PET/CT as an Imaging Biomarker Measuring Response to Cancer Therapy, Quantitative Imaging Biomarkers Alliance, Version 1.05, Publicly Reviewed Version. RSNA Web site
Fdg-PetCt Technical Committee
Lung nodule classification using learnt texture features on a single patient population [abstr]
L Pickup (2015)
A semiautomatic CT-based ensemble segmentation of lung tumors: comparison with oncologists' delineations and with the surgical specimen.
E. Rios Velazquez (2012)
Quantifying spatial heterogeneity in dynamic contrast‐enhanced MRI parameter maps
C. J. Rose (2009)
The QIBA profile for quantitative FDG-PET/CT oncology imaging
P. Kinahan (2014)
A call for transparent reporting to optimize the predictive value of preclinical research
S. Landis (2012)
Radiomics: extracting more information from medical images using advanced feature analysis.
P. Lambin (2012)
Institute of Medicine I. Evolution of Translational Omics. Lessons learned and the path forward
Test–Retest Reproducibility Analysis of Lung CT Image Features
Yoganand Balagurunathan (2014)
Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling.
N. Wagle (2011)
Historical Perspective and Planned Goals
Use of archived specimens in evaluation of prognostic and predictive biomarkers.
R. Simon (2009)
matic EGFR mutations
Quantitative Computed Tomographic Descriptors Associate Tumor Shape Complexity and Intratumor Heterogeneity with Prognosis in Lung Adenocarcinoma
O. Grove (2015)
Improving target delineation on 4-dimensional CT scans in stage I NSCLC using a deformable registration tool.
I. V. van Dam (2010)
Transparent and accurate reporting increases reliability, utility, and impact of your research: reporting guidelines and the EQUATOR Network
I. Simera (2010)
Imaging Intratumor Heterogeneity: Role in Therapy Response, Resistance, and Clinical Outcome
J. O'Connor (2014)
Evaluating RadLex and real world radiology reporting: are we there yet?
M. Heilbrun (2013)
Distant Metastasis Occurs Late during the Genetic Evolution of Pancreatic Cancer
S. Yachida (2010)
Avoidable waste in the production and reporting of research evidence
I. Chalmers (2009)
Quantitative imaging in cancer evolution and ecology.
R. Gatenby (2013)
Textural Features for Image Classification
R. Haralick (1973)
A concordance correlation coefficient to evaluate reproducibility.
L. Lin (1989)
Journals unite for reproducibility
Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics
A. Sottoriva (2013)
Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: multicenter phase II trial with clinical outcomes, analysis of serum tumor markers as predictive factors, and cardiac surveillance algorithm.
H. Burstein (2003)
Believe it or not: how much can we rely on published data on potential drug targets?
F. Prinz (2011)
Update on the potential of computer-aided diagnosis for breast cancer.
M. Giger (2010)
The Quantitative Imaging Network: NCI's Historical Perspective and Planned Goals.
L. Clarke (2014)
Radiogenomics helps to achieve personalized therapy by evaluating patient responses to radiation treatment.
Z. Guo (2015)
Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice?
Fergus Davnall (2012)
N. Dubrawsky (1989)
Haralick texture analysis of prostate MRI: utility for differentiating non-cancerous prostate from prostate cancer and differentiating prostate cancers with different Gleason scores
A. Wibmer (2015)
Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors
L. Sequist (2011)
A collaborative enterprise for multi-stakeholder participation in the advancement of quantitative imaging.
A. Buckler (2011)
First-line gefitinib in patients with advanced non-small-cell lung cancer harboring so-Radiomics Resources Readers may find the following resources helpful: QIN
L V Sequist
References 1. Institute of Medicine I. Evolution of Translational Omics. Lessons learned and the path forward
Drug Food (2012)
Radiologically defined ecological dynamics and clinical outcomes in glioblastoma multiforme: preliminary results.
M. Zhou (2014)
Glioblastoma Multiforme: Exploratory Radiogenomic Analysis by Using Quantitative Image Features.
O. Gevaert (2015)
Analysis of image heterogeneity using 2D Minkowski functionals detects tumor responses to treatment
T. Larkin (2014)
Sackler Colloquia of the National Academy of Sciences
Identification of molecular phenotypes in lung cancer by integrating radiomics and genomics
Lung nodule classification using learnt texture features on a single patient population
L Pickup (2015)
Radiomics: the process and the challenges.
Virendra Kumar (2012)
Annotation of figures from the biomedical imaging literature: a comparative analysis of RadLex and other standardized vocabularies.
C. E. Kahn (2014)
Cancer statistics, 2014
R. Siegel (2014)
A new initiative on precision medicine.
F. Collins (2015)
The Quantitative Imaging Network: NCI's SPECIAL REPORT: Radiomics Gillies et al
Dynamic contrast‐enhanced MRI texture analysis for pretreatment prediction of clinical and pathological response to neoadjuvant chemotherapy in patients with locally advanced breast cancer
J. R. Teruel (2014)
The use of central laboratories and remote electronic data capture to risk-adjust therapy for pediatric acute lymphoblastic leukemia and neuroblastoma.
M. Devidas (2010)
Mandatory second opinion surgical pathology at a large referral hospital
R. Sirota (2000)
ture features on T 2 - weighted magnetic resonance imaging : new potential biomarkers for prostate cancer aggressiveness
A Vignati (2015)
Dynamic contrast - enhanced MRI texture analysis for pretreatment prediction of clinical and pathological response to neoadju - vant chemotherapy in patients with locally advanced breast cancer
Teruel JRHM (2014)
Radiogenomics helps to achieve personalized 41. Haralick RM, Shanmugam K, Dinstein I. Textural features for image classification
Z Guo (1973)
Imaging as a Biomarker: Standards for Change Measurements in Therapy workshop summary.
L. Clarke (2008)
The Cancer Imaging Archive (TCIA): Maintaining and Operating a Public Information Repository
K. Clark (2013)
Drawing causal inference from Big Data
R. Shiffrin (2016)
Differences in Patient Outcomes of Prevalence, Interval, and Screen-Detected Lung Cancers in the CT Arm of the National Lung Screening Trial
M. Schabath (2016)
PET/CT-guided biopsies of metabolically active bone lesions: applications and clinical impact
B. Klaeser (2010)
Changes in breast cancer therapy because of pathology second opinions
V. Staradub (2007)
Glioblastoma multiforme: exploratory radiogenomic analysis by using quantitative image features.
O. Gevaert (2014)
Automatic classification of prostate cancer Gleason scores from multiparametric magnetic resonance images
D. Fehr (2015)
Abdominal masses sampled at PET/CT-guided percutaneous biopsy: initial experience with registration of prior PET/CT images.
S. Tatli (2010)
Genetics and genomics of radiotherapy toxicity: towards prediction
C. West (2011)
Identification of noninvasive imaging surrogates for brain tumor gene-expression modules
M. Diehn (2008)
Behavior of incidence lung cancers in the CT arm of the National Lung Screening Trial
This paper is referenced by
Image biomarker standardisation initiative
A. Zwanenburg (2016)
Unsupervised Histopathology Image Synthesis
Le Hou (2017)
Radiomics approach for preoperative identification of stages I−II and III−IV of esophageal cancer
L. Wu (2018)
Radiomic Texture Analysis Mapping Predicts Areas of True Functional MRI Activity
Islam A. Hassan (2016)
Artificial intelligence and nuclear medicine
Margaret L Hall (2019)
Prediction of 90Y Radioembolization Outcome from Pretherapeutic Factors with Random Survival Forests
M. Ingrisch (2018)
Images Are More than Documentation: They Are ResearchData
Faten Dhawi (2018)
Personalized dosimetry protocol for the optimization of lutetium-177 DOTATATE radionuclide therapy
Wei Zhao (2019)
Prognostic Prediction of Lung Cancer Patients Using Random Survival Forest
T. Yoshioka (2019)
The utility of quantitative CT radiomics features for improved prediction of radiation pneumonitis
S. Krafft (2018)
Longitudinal medical imaging approaches for characterization of porcine cancer models
E. Hammond (2017)
Radiomics‐based Assessment of Radiation‐induced Lung Injury After Stereotactic Body Radiotherapy
Angel Moran (2017)
Radiomics-based classification of hepatocellular carcinoma and hepatic haemangioma on precontrast magnetic resonance images
J. Wu (2019)
Prediction of adverse motor outcome for neonates with punctate white matter lesions by MRI images using radiomics strategy: protocol for a prospective cohort multicentre study
M. Wang (2019)
Development and clinical application of radiomics in lung cancer
Bojiang Chen (2017)
MRI radiomics analysis of molecular alterations in low-grade gliomas
B. Shofty (2017)
Deep Learning based Radiomics (DLR) and its usage in noninvasive IDH1 prediction for low grade glioma
Zeju Li (2017)
Introduction to Radiomics
M. Mayerhoefer (2020)
Artificial Intelligence in medical imaging practice: looking to the future
S. Lewis (2019)
Radiomics in Nuclear Medicine Applied to Radiation Therapy: Methods, Pitfalls, and Challenges.
S. Reuzé (2018)
The Top Three Health Care Developments Impacting the Practice of Interventional Radiology in the Next Decade.
S. Kwan (2016)
Multi-modal radiomics model to predict treatment response to neoadjuvant chemotherapy for locally advanced rectal cancer
Zheng-yan Li (2020)
Radiomic signature: a non-invasive biomarker for discriminating invasive and non-invasive cases of lung adenocarcinoma
Bin Yang (2019)
About New Health Technologies An Overview of Clinical Applications of Artificial Intelligence
J. Mason (2018)
Comparison of machine learning algorithms to predict clinically significant prostate cancer of the peripheral zone with multiparametric MRI using clinical assessment categories and radiomic features
Simon Bernatz (2020)
MR imaging of epithelial ovarian cancer: a combined model to predict histologic subtypes
LuoDan Qian (2020)
Contrast-Enhanced Mammography and Radiomics Analysis for Noninvasive Breast Cancer Characterization: Initial Results
M. A. Marino (2019)
DTI-based radiomics signature for the detection of early diabetic kidney damage
Yi Deng (2020)
Machine learning in breast MRI
B. Reig (2019)
AI in Medical Imaging Informatics: Current Challenges and Future Directions
Andreas S. Panayides (2020)
Amide Proton Transfer Imaging in Predicting Isocitrate Dehydrogenase 1 Mutation Status of Grade II/III Gliomas Based on Support Vector Machine
Y. Han (2020)
Assessment of liver metastases radiomic feature reproducibility with deep-learning-based semi-automatic segmentation software.
L. Wang (2020)See more